Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infections. Chemaitelly H, Ayoub HH, AlMukdad S, Faust JS, et al. J Travel Med 2023 Aug 9:taad106. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chemaitelly H, Ayoub HH, AlMukdad S, Faust JS, et al. Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infections. J Travel Med 2023 Aug 9:taad106. doi: 10.1093.
PMID: 37555656